Officials at SIX, the Swiss stock exchange where Synthes shares trade, have begun looking into a spike in the company’s shares before it disclosed talks to be taken over by U.S. health-care company Johnson & Johnson, according to people familiar with the situation. If the probe turns up evidence of insider trading, stock-market officials could refer the case for further investigation to Zurich’s prosecutor.
Subscribe
‘Enforcement 40’ for 2020
Our Sponsors
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn